Bayer Aktiengesellschaft (BAYRY)
OTCMKTS
· Delayed Price · Currency is USD
6.01
-0.13 (-2.17%)
Mar 31, 2025, 3:51 PM EST
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 90,587 employees as of December 31, 2024. The number of employees decreased by 6,344 or -6.54% compared to the previous year.
Employees
90,587
Change (1Y)
-6,344
Growth (1Y)
-6.54%
Revenue / Employee
$532,652
Profits / Employee
-$29,166
Market Cap
24.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 90,587 | -6,344 | -6.54% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
| American Oncology Network | 1,525 |
Bayer Aktiengesellschaft News
- 5 days ago - Elliott held talks with private equity as it considered new Bayer campaign - Financial Times
- 5 days ago - Bayer in licenses Puhe BioPharma’s cancer candidate - Seeking Alpha
- 5 days ago - Bayer acquires rights in Puhe BioPharma cancer drug candidate - Reuters
- 6 days ago - ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes - Business Wire
- 6 days ago - Bayer told to pay almost $2.1bn over Roundup cancer link claim - Independent Ireland
- 6 days ago - Monsanto parent ordered to pay $2B in Roundup lawsuit damages - The Hill
- 7 days ago - Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case - Investopedia
- 7 days ago - Push-pull over glyphosate in Germany - EURACTIV.com